Bacterial superinfection of disrupted mucosal barrier follows
Influenza A most commonly implicated viral trigger in 72% of viral cultures
Tracheal pathology
Intense subglottic mucosal edema and inflammation
Copious mucopurulent exudate production
Pseudomembrane formation adherent to tracheal wall
Intraluminal obstruction from membranes and secretions
Microbiology
Staphylococcus aureus most common causative pathogen
Both MSSA and MRSA implicated
Toxin-producing strains may worsen severity
Other causative organisms
Group A Streptococcus
Moraxella catarrhalis
Streptococcus pneumoniae
Haemophilus influenzae
Polymicrobial infection in subset of cases
Therapeutic Considerations
Antibiotic strategy principles
Empiric coverage must include MSSA and consider MRSA
Local MRSA prevalence guides initial vancomycin addition
Anti-staphylococcal agent essential in all empiric regimens
Antibiotic duration 10 to 14 days total course
IV to oral transition when clinically improved
Guided by culture results for de-escalation
Early surgical evaluation essential
Rigid tracheobronchoscopy for definitive diagnosis and debridement
Cannot rely on antibiotics alone without airway clearance
Airway management principles
Anticipatory approach preferred over reactive
Controlled intubation in OR superior to emergency intubation
Delay in airway management associated with higher morbidity
Post-intubation management
Humidified circuit prevents mucus plugging
Regular suctioning protocol
Extubation when secretions manageable and edema resolved typically 3 to 7 days
Ineffective therapies
Nebulized epinephrine not definitive treatment
Temporary relief only
Lack of response is diagnostic clue
Steroids not effective unlike viral croup
No evidence supporting routine corticosteroid use in bacterial tracheitis
May delay diagnosis if bacterial etiology not considered
Patient Discharge Instructions
copy discharge instructions
Bacterial tracheitis recovery instructions
Antibiotic course completion
Take all prescribed antibiotics as directed even if feeling better
Total course typically 10 to 14 days
Activity and recovery
Rest at home until fully recovered
Avoid daycare or school until fever-free for 24 hours and breathing normal
Hydration and nutrition
Encourage oral fluids once tolerated
Soft diet initially if throat soreness persists
Warning signs requiring immediate return to emergency department
Breathing changes
Any new stridor or noisy breathing
Increased work of breathing or retractions
Lips or fingertips turning blue
Fever and systemic signs
Fever returning after initial improvement
Appearing toxic or very unwell
Unusual sleepiness or difficulty waking
Other urgent symptoms
Inability to swallow or handle secretions
Inability to maintain oral intake
Parents or caregivers with concern about child's condition
Follow-up plan
Pediatrician or family physician follow up within 1 to 2 days of discharge
ENT follow up if recommended by hospital team
Return for any worsening before scheduled appointment
References
Guidelines and key sources
Clinical guideline sources
Pediatric Infectious Diseases Society and IDSA antimicrobial therapy guidance
American Academy of Pediatrics croup and upper airway infection resources
Surviving Sepsis Campaign pediatric guidelines
Key literature
Hopkins A et al case series characterizing bacterial tracheitis demographics intubation rates and microbiology
Donaldson JD and Maltby CC series reporting epinephrine failure as cardinal diagnostic feature
Bernstein T et al series reporting influenza A in 72% of viral cultures and younger age intubation risk
Case series reporting PICU admission in 69% and intubation in 43% and respiratory arrest in 2.7%
Coding references
ICD-10 J04.1 acute tracheitis
ICD-10 J04.10 acute tracheitis without obstruction
ICD-10 J04.11 acute tracheitis with obstruction
SNOMED CT bacterial tracheitis disorder concept
SymptomDx is an educational tool for medical professionals. It does not replace clinical judgment. Verify all clinical data and drug dosages with authoritative sources.